Mer information om produkten
Banderoll är mycket effektivt mot Borrelia burgdorferi och de gemensamma samtidiga infektioner i borrelia. Banderoll dödar också vissa svampar som Cumanda inte gör det. Vissa mikrober behandlas av Banderoll:
Anaeroba och aeroba stavar och cocci (många), Aspergillus (vissa), Babesia, Bartonella, Borrelia, Candida (en del), Chlamydia, Cytomegalovirus, encefalitvirus (vissa ), hepatitvirus (vissa), humana papillomvirus (vissa), Mucor (vissa), Mycoplasma, Mycosis fungoides, protozoiska parasiter (många), Rickettsia (inklusive Coxiella och Erlichia).
Vissa villkor behandlas av Banderoll: Akut och kronisk prostatit, Akuta och kroniska luftvägsinfektioner (många), akut och kronisk bihåleinflammation, astma, aterosklerotisk sjukdom, cellulit, Matförgiftning, borrelia, Parkinsons sjukdom, psoriasis, trast, Urinvägsinfektioner (många), vaginala infektioner.
Farmakologiska studier genomfördes vid universitetet i Guayaquil i Ecuador. I en anti-inflammatorisk effekt Study Nutramedix banderoll hämmade inflammation med 84,4%. Det jämfördes med Pfizers mest sålda och mycket giftiga antiinflammatoriska läkemedel, Feldene (Piroxicam), vilket hämmade inflammation 85,6% vilket gör banderoll 98,6% så effektiv som Feldene som en anti-inflammatorisk. I en annan farmakologisk studie banderoll visade sig vara en effektiv antidiarrheal.
Det finns inga kända kontraindikationer, inga kända biverkningar och inga kända interaktioner med andra läkemedel vid användning Otoba sp. produkter som banderoll. Toxikologiska studier har genomförts på Nutramedix banderoll vid universitetet i Guayaquil i Ecuador. Inga toxiska effekter har rapporterats även om smågnagare fick 88.000 gånger den ekvivalenta dosen till människa.
BANDEROL / MICROBIAL DEFENSE is an extract produced from the bark of the Otoba sp., a tree that is found in South America. Nutramedix utilizes a proprietary extraction andenhancement process that makes this product more effective than any other Otoba sp. product available.
Known medicinal properties include:
BROAD SPECTRUM ANTIVIRAL BROAD SPECTRUM ANTIFUNGAL BROAD SPECTRUM ANTIBACTERIAL BROAD SPECTRUM ANTIPARASITIC ANTIMYCOPLASMA ANTIPROTOZOAL ANTIRICKETTSIAL ANTI-INFLAMMATORY Banderol is very effective against Borrelia burgdorferi and the common co-infections in Lyme disease. Banderol also kills some fungi that Cumanda does not.
Some MICROBES treated by BANDEROL: Anaerobic and Aerobic rods and cocci (many), Aspergillus (some), Babesia, Bartonella, Borrelia, Candida (some), Chlamydia, Cytomegalovirus, Encephalitis viruses (some), Hepatitis viruses (some), Human Papilloma Viruses (some), Mucor (some), Mycoplasma, Mycosis fungoides, Protozoal parasites (many), Rickettsia (including Coxiella and Erlichia).
Some CONDITIONS treated by BANDEROL: Acute and Chronic prostatitis, Acute and Chronic respiratory tract infections (many), Acute and Chronic sinusitis, Asthma, Atherosclerotic disease, Cellulitis, Food poisoning, Lyme disease, Parkinson''''''''s disease, Psoriasis, Thrush, Urinary tract infections (many), Vaginal infections.
Pharmacological studies were conducted at the University of Guayaquil in Ecuador. In an Anti-inflammatory Effect Study Nutramedix Banderol inhibited inflammation by 84.4%. It was compared with Pfizer''''''''s best selling and very toxic anti-inflammatory drug, Feldene (Piroxicam), which inhibited inflammation 85.6% making Banderol 98.6% as effective as Feldene as an anti-inflammatory. In another pharmacology study Banderol was found to be an effective Antidiarrheal.
There are no known contraindications, no known side effects and no known interactions with other drugs when using Otoba sp. products like Banderol. Toxicology studies were conducted on Nutramedix Banderol at the University of Guayaquil in Ecuador. No toxic effects were reported even when laboratory rodents received 88,000 times the equivalent human dose.
|
.png)
Anatomiska planscher.png)
Hälsa, Skönhet & Samliv
Kristallsmycken
Mode & Accessoarer
Party Maskerad Dräkter.png)
Present.png)
Sport & Friluft.png)
Sökaren....png)
Vattenfilter
